We examined the dependency of hCasp12′s catalytic site in limited NF-κB activation by VC12-transfected NPC cells, which expressed mutant hCasp12 that mutated the catalytic site (Figure 6). The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.